跳至主要内容
临床试验/JPRN-UMIN000010827
JPRN-UMIN000010827已完成未知

Comparative effect of second-generation antipsychotic blonanserin and aripiprazole on cognitive impairment in first-episode schizophrenia: An open-label trial - Effect of second-generation antipsychotics on cognition in first-episode schizophrenia

Department of Neuropsychiatry St. Marianna University School of Medicine0 个研究点目标入组 60 人开始时间: 2013年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 40years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) patients who had been treated with blonanserin or aripiprazole before study entry 2) comorbid central nervous system disorder 3) meeting DSM-IV-TR criteria for alcohol or other substance dependence 4) meeting DSM-IV-TR criteria for mental retardation 5) symptomatic or organic psychosis (including dementia) 6) taking tricyclic antidepressants 7) treatment with electroconvulsive therapy in the 12 weeks preceding the study 8) treatment with long-acting antipsychotics in the 12 weeks preceding the study 9) patients who are not voluntarily hospitalized 10) active expression of suicidal or homicidal ideation 11) pregnancy or breast feeding 12) inability to understand the study protocol

研究者

发起方
Department of Neuropsychiatry St. Marianna University School of Medicine

相似试验